@article{aaac71a1a5444026ac7cd26a8688bd73,
title = "The serotonin transporter sustains human brown adipose tissue thermogenesis",
abstract = "Activation of brown adipose tissue (BAT) in humans is a strategy to treat obesity and metabolic disease. Here, we show that the serotonin transporter SERT, encoded by SLC6A4, prevents serotonin-mediated suppression of human BAT function. RNA sequencing of human primary brown and white adipocytes shows that SLC6A4 is highly expressed in human, but not murine, brown adipocytes and BAT. Serotonin decreases uncoupled respiration and reduces uncoupling protein 1 via the 5-HT2B receptor. SERT inhibition by the selective serotonin reuptake inhibitor (SSRI) sertraline prevents uptake of extracellular serotonin, thereby potentiating serotonin{\textquoteright}s suppressive effect on brown adipocytes. Furthermore, we see that sertraline reduces BAT activation in healthy volunteers, and SSRI-treated patients demonstrate no 18F-fluorodeoxyglucose uptake by BAT at room temperature, unlike matched controls. Inhibition of BAT thermogenesis may contribute to SSRI-induced weight gain and metabolic dysfunction, and reducing peripheral serotonin action may be an approach to treat obesity and metabolic disease.",
author = "Suchacki, \{Karla J\} and Ramage, \{Lynne E\} and \{Choong Kwok\}, T'ng and Alexandra Kelman and McNeill, \{Ben T\} and Stewart Rodney and Matthew Keegan and Calum Gray and Gillian MacNaught and Dilip Patel and Fletcher, \{Alison M\} and Simpson, \{Joanna P\} and \{N Carter\}, Roderick and Semple, \{Robert K\} and Homer, \{Natalie Z M\} and Morton, \{Nicholas M\} and \{van Beek\}, \{Edwin J R\} and Wakelin, \{Sonia J\} and Stimson, \{Roland H\}",
note = "Funding Information: This work was supported by grants from the Medical Research Council (MR/K010271/1, MR/S035761/1), the Chief Scientist Office (SCAF/17/02) and the British Heart Foundation (RE/18/5/34216) to R.H.S. We acknowledge the financial support of NHS Research Scotland (NRS) for the Mass Spectrometry Core (RRID:SCR\_021833) through the Edinburgh Clinical Research Facility (ECRF) with data collected on the AB SCIEX QTRAP 6500+ instrument (RRID:SCR\_021831). R.K.S. is supported by the Wellcome Trust (grant 210752/Z/18/Z). We thank L. Grisales-Pastor and the other nurses at the Clinical Research Facility, and the radiographers and S. Semple at the Edinburgh Imaging Facility for their assistance. We thank J. Manning at the Centre for Regenerative Medicine at the University of Edinburgh for his assistance. We acknowledge the technical support of S. Denham and P. Lee at the Mass Spectrometry Core facility, L. Murphy, A. Fawkes, A. Coutts and R. Clark at the ECRF Genetics Core and M. Sinton at the University of Glasgow. We also acknowledge the assistance of C. Scheele at the University of Copenhagen and the NHS Scotland Pharmaceutical {\textquoteleft}Specials{\textquoteright} Service. Recruitment to one of the human studies was facilitated by SHARE, the Scottish Health Research Register. SHARE is supported by NRS and the Chief Scientist Office. Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
month = aug,
day = "3",
doi = "10.1038/s42255-023-00839-2",
language = "English",
volume = "5",
pages = "1319--1336",
journal = "Nature Metabolism",
issn = "2522-5812",
publisher = "Springer",
}